These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7657507)

  • 1. Identification of molecules associated with the development of metastasis in human malignant melanoma.
    Johnson JP
    Invasion Metastasis; 1994-1995; 14(1-6):123-30. PubMed ID: 7657507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional aspects of three molecules associated with metastasis development in human malignant melanoma.
    Johnson JP; Lehmann JM; Stade BG; Rothbächer U; Sers C; Riethmüller G
    Invasion Metastasis; 1989; 9(6):338-50. PubMed ID: 2574717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of adhesion molecules as markers of progression in malignant melanoma.
    Denton KJ; Stretch JR; Gatter KC; Harris AL
    J Pathol; 1992 Jun; 167(2):187-91. PubMed ID: 1378891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule).
    Degen WG; van Kempen LC; Gijzen EG; van Groningen JJ; van Kooyk Y; Bloemers HP; Swart GW
    Am J Pathol; 1998 Mar; 152(3):805-13. PubMed ID: 9502422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell distribution and adhesion receptor expression in metastatic melanoma.
    Weishaupt C; Munoz KN; Buzney E; Kupper TS; Fuhlbrigge RC
    Clin Cancer Res; 2007 May; 13(9):2549-56. PubMed ID: 17473183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions.
    Natali PG; Hamby CV; Felding-Habermann B; Liang B; Nicotra MR; Di Filippo F; Giannarelli D; Temponi M; Ferrone S
    Cancer Res; 1997 Apr; 57(8):1554-60. PubMed ID: 9108459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the expression of intercellular adhesion molecule-1 and MUC18 on benign and malignant melanocytic lesions using monoclonal antibodies directed against distinct epitopes and recognizing denatured, non-glycosylated antigen.
    Kraus A; Masat L; Johnson JP
    Melanoma Res; 1997 Aug; 7 Suppl 2():S75-81. PubMed ID: 9578420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced metastatic ability of TNF-alpha-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, CD54) antisense oligonucleotides.
    Miele ME; Bennett CF; Miller BE; Welch DR
    Exp Cell Res; 1994 Sep; 214(1):231-41. PubMed ID: 7915992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma.
    Kageshita T; Yoshii A; Kimura T; Kuriya N; Ono T; Tsujisaki M; Imai K; Ferrone S
    Cancer Res; 1993 Oct; 53(20):4927-32. PubMed ID: 8104688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
    Mills L; Tellez C; Huang S; Baker C; McCarty M; Green L; Gudas JM; Feng X; Bar-Eli M
    Cancer Res; 2002 Sep; 62(17):5106-14. PubMed ID: 12208768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression.
    Dirkx AE; Oude Egbrink MG; Kuijpers MJ; van der Niet ST; Heijnen VV; Bouma-ter Steege JC; Wagstaff J; Griffioen AW
    Cancer Res; 2003 May; 63(9):2322-9. PubMed ID: 12727857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of malignant melanoma: disease progression correlated with serum levels of 5-S-Cysteinyldopa (5-S-CD) and intercellular adhesion molecule-1 (ICAM-1).
    Ye Z; Kageshita T; Ishihara T; Ito S; Ono T
    J Dermatol; 1995 May; 22(5):370-5. PubMed ID: 7673560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CD146 (Mel-CAM) in biology and pathology.
    Shih IM
    J Pathol; 1999 Sep; 189(1):4-11. PubMed ID: 10451481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC18, a melanoma-progression associated molecule, and its potential role in tumor vascularization and hematogenous spread.
    Sers C; Riethmüller G; Johnson JP
    Cancer Res; 1994 Nov; 54(21):5689-94. PubMed ID: 7923217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma cell-cell interactions are mediated through heterophilic Mel-CAM/ligand adhesion.
    Shih IM; Speicher D; Hsu MY; Levine E; Herlyn M
    Cancer Res; 1997 Sep; 57(17):3835-40. PubMed ID: 9288796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of ICAM-1 in tumor development.
    Johnson JP
    Chem Immunol; 1991; 50():143-63. PubMed ID: 1686176
    [No Abstract]   [Full Text] [Related]  

  • 18. Activated leukocyte cell adhesion molecule (ALCAM/CD166): signaling at the divide of melanoma cell clustering and cell migration?
    Swart GW; Lunter PC; Kilsdonk JW; Kempen LC
    Cancer Metastasis Rev; 2005 Jun; 24(2):223-36. PubMed ID: 15986133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a melanoma cell line with metastatic characteristics.
    Enjoji M; Nakashima M; Sakai H; Nawata H
    Hum Cell; 1995 Sep; 8(3):115-20. PubMed ID: 8652447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoluminescent detection of intercellular adhesion molecule-1 and aminopeptidase N on human melanoma cells.
    Laube F
    Anticancer Res; 2007; 27(4A):2047-52. PubMed ID: 17649820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.